{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:37:49Z","timestamp":1794685069512,"version":"4.9.1"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To develop the first evidence-based Pan American League of Associations for Rheumatology (PANLAR) guidelines for the treatment of Takayasu arteritis (TAK).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A panel of vasculitis experts developed a series of clinically meaningful questions addressing the treatment of TAK patients in the PICO (population\/intervention\/comparator\/outcome) format. A systematic literature review was performed by a team of methodologists. The evidence quality was assessed according to the GRADE (Grading of Recommendations\/Assessment\/Development\/Evaluation) methodology. The panel of vasculitis experts voted each PICO question and made recommendations, which required \u226570% agreement among the voting members.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eleven recommendations were developed. Oral glucocorticoids are conditionally recommended for newly diagnosed and relapsing TAK patients. The addition of nontargeted synthetic immunosuppressants (e.g., methotrexate, leflunomide, azathioprine, or mycophenolate mofetil) is recommended for patients with newly diagnosed or relapsing disease that is not organ- or life-threatening. For organ- or life-threatening disease, we conditionally recommend tumor necrosis factor inhibitors (e.g., infliximab or adalimumab) or tocilizumab with consideration for short courses of cyclophosphamide as an alternative in case of restricted access to biologics. For patients relapsing despite nontargeted synthetic immunosuppressants, we conditionally recommend to switch from one nontargeted synthetic immunosuppressant to another or to add tumor necrosis factor inhibitors or tocilizumab. We conditionally recommend low-dose aspirin for patients with involvement of cranial or coronary arteries to prevent ischemic complications. We strongly recommend performing surgical vascular interventions during periods of remission whenever possible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The first PANLAR treatment guidelines for TAK provide evidence-based guidance for the treatment of TAK patients in Latin American countries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rhu.0000000000002004","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:05:28Z","timestamp":1691539528000},"page":"316-325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Pan American League of Associations for Rheumatology Guidelines for the Treatment of Takayasu Arteritis"],"prefix":"10.1097","volume":"29","author":[{"given":"Alexandre Wagner S.","family":"de Souza","sequence":"first","affiliation":[{"name":"Rheumatology Division, Universidad Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia I.","family":"Sato","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Universidad Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorena","family":"Brance","sequence":"additional","affiliation":[{"name":"School of Medicine, Rosario National University, Santa Fe, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Fern\u00e1ndez-\u00c1vila","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio. Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scolnik","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital, Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n Juan","family":"Magri","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital Italiano de La Plata, La Plata, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Francisco","family":"Ugarte-Gil","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad Cientifica del Sur, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Flores-Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Primary Systemic Vasculitides Clinic, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Mar\u00eda","family":"Saldarriaga-Rivera","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital Universitario San Jorge, Risaralda, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Babini","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital Italiano de Cordoba, Cordoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Zamora","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital San Jose, Pergamino, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Acosta Felquer","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital, Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo","family":"Vergara","sequence":"additional","affiliation":[{"name":"Immunology Unit, Hospital Central, Mendoza, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Carlevaris","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital Privado de Mendoza, Godoy Cruz, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Scarafia","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital Municipal San Cayetano, Virreyes, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique Roberto","family":"Soriano Guppy","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Hospital, Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Unizony","sequence":"additional","affiliation":[{"name":"Vasculitis and Glomerulonephritis Center, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"bib1-20250802","first-page":"79","article-title":"Diagnostic and classification criteria of Takayasu arteritis","volume":"48\u201349","year":"2014","journal-title":"J Autoimmun"},{"key":"bib2-20250802","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/03009742.2019.1581838","article-title":"Gender differences in clinical presentation and vascular pattern in patients with Takayasu arteritis","volume":"48","year":"2019","journal-title":"Scand J Rheumatol [Internet]"},{"key":"bib3-20250802","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(00)02701-X","article-title":"Takayasu's arteritis","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"7\u20138 Pt 2","key":"bib5-20250802","first-page":"e197","article-title":"Epidemiology of Takayasu arteritis","volume":"46","year":"2017","journal-title":"Presse Med"},{"issue":"7S Suppl 2","key":"bib6-20250802","first-page":"S106","article-title":"Epidemiologic features of systemic vasculitides in the Southeast Region of Brazil: hospital-based survey","volume":"26","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"bib7-20250802","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10067-021-06032-8","article-title":"Different epidemiologic profiles of systemic vasculitis between Brazil and Peru\u2014preliminary results in two referral centers from both countries","volume":"41","year":"2022","journal-title":"Clin Rheumatol"},{"key":"bib8-20250802","first-page":"248","article-title":"Epidemiolog\u00eda de las vasculitis primarias en Colombia y su relaci\u00f3n con lo informado para Latinoam\u00e9rica","volume":"16","year":"2009","journal-title":"Rev. Colomb. Reumatol"},{"key":"bib9-20250802","article-title":"The epidemiology of Takayasu arteritis in Rio de Janeiro, Brazil: a large population-based study","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.autrev.2018.01.019","article-title":"Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: a systematic review and meta-analysis","volume":"17","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"Suppl","key":"bib11-20250802","first-page":"S99","article-title":"Takayasu arteritis: lessons from the American National Institutes of Health experience","volume":"54","year":"1996","journal-title":"Int J Cardiol"},{"key":"bib12-20250802","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/rheumatology\/ket320","article-title":"Management of Takayasu arteritis: a systematic review","volume":"53","year":"2014","journal-title":"Rheumatology (Oxford) [Internet]"},{"issue":"7\u20138 Pt 2","key":"bib13-20250802","first-page":"e229","article-title":"What is new in management of Takayasu arteritis?","volume":"46","year":"2017","journal-title":"Presse Med"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/rheumatology\/kex249","article-title":"Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature","volume":"57","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41572-021-00327-5","article-title":"Large-vessel vasculitis","volume":"7","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.116.027094","article-title":"Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients","volume":"136","year":"2017","journal-title":"Circulation"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","year":"2011","journal-title":"J Clin Epidemiol [Internet]"},{"key":"bib18-20250802","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","year":"2010","journal-title":"CMAJ [Internet]"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.22404","article-title":"Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients","volume":"56","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3 Suppl 49","key":"bib20-20250802","first-page":"S9","article-title":"Takayasu arteritis: Clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis","volume":"26","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1 Suppl 52","key":"bib22-20250802","first-page":"S59","article-title":"Takayasu's arteritis in Turkey\u2014clinical and angiographic features of 248 patients","volume":"27","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00296-010-1694-9","article-title":"Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques","volume":"32","year":"2012","journal-title":"Rheumatol Int"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3899\/jrheum.181219","article-title":"Insufficient use of corticosteroids without immunosuppressants results in higher relapse rates in Takayasu arteritis","volume":"47","year":"2020","journal-title":"J Rheumatol"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jjcc.2016.07.009","article-title":"Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment","volume":"69","year":"2017","journal-title":"J Cardiol"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-020-00961-0","article-title":"Reducing the toxicity of long-term glucocorticoid treatment in large vessel vasculitis","volume":"22","year":"2020","journal-title":"Curr Rheumatol Rep [Internet]"},{"key":"bib27-20250802","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.1780370420","article-title":"Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate","volume":"37","year":"1994","journal-title":"Arthritis Rheum"},{"key":"bib28-20250802","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10067-009-1333-6","article-title":"Mycophenolate mofetil in Takayasu's arteritis","volume":"29","year":"2010","journal-title":"Clin Rheumatol"},{"key":"bib29-20250802","doi-asserted-by":"crossref","first-page":"2040622320975233","DOI":"10.1177\/2040622320975233","article-title":"Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis","volume":"11","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"bib30-20250802","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00296-017-3847-6","article-title":"Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis","volume":"37","year":"2017","journal-title":"Rheumatol Int"},{"key":"bib31-20250802","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/03009742.2011.633553","article-title":"Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study","volume":"41","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"bib32-20250802","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rbr.2015.09.007","article-title":"Leflunomide in Takayasu arteritis\u2014a long term observational study","volume":"56","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"bib33-20250802","doi-asserted-by":"crossref","first-page":"2040622320922019","DOI":"10.1177\/2040622320922019","article-title":"Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study","volume":"11","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"bib34-20250802","first-page":"1793","article-title":"Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis","volume":"30","year":"2003","journal-title":"J Rheumatol"},{"key":"bib35-20250802","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10067-007-0596-z","article-title":"Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis","volume":"26","year":"2007","journal-title":"Clin Rheumatol"},{"key":"bib36-20250802","doi-asserted-by":"crossref","first-page":"38687","DOI":"10.1038\/srep38687","article-title":"The efficacy of mycophenolate mofetil for the treatment of Chinese Takayasu's arteritis","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"bib37-20250802","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-017-1316-y","article-title":"TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study","volume":"19","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"bib38-20250802","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10067-013-2380-6","article-title":"Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature","volume":"32","year":"2013","journal-title":"Clin Rheumatol"},{"key":"bib39-20250802","first-page":"723506","article-title":"A prospective observational study on the efficacy and safety of infliximab-biosimilar (CT-P13) in patients with Takayasu arteritis (TAKASIM)","volume":"8","year":"2021","journal-title":"Front Med (Lausanne) [Internet]"},{"key":"bib40-20250802","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/acr.21636","article-title":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup","volume":"64","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"bib41-20250802","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/ard.2008.093260","article-title":"Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up","volume":"67","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"bib42-20250802","first-page":"922","article-title":"Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab","volume":"30","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"bib43-20250802","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.114.014321","article-title":"Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients","volume":"132","year":"2015","journal-title":"Circulation"},{"key":"bib44-20250802","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s10067-006-0227-0","article-title":"Infliximab in Takayasu arteritis: a safe alternative?","volume":"26","year":"2007","journal-title":"Clin Rheumatol"},{"key":"bib45-20250802","doi-asserted-by":"crossref","first-page":"e115026","DOI":"10.1371\/journal.pone.0115026","article-title":"The role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysis","volume":"9","year":"2014","journal-title":"PloS One"},{"key":"bib46-20250802","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Anti\u2013tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis","volume":"50","year":"2004","journal-title":"Arthritis Rheum"},{"key":"bib47-20250802","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2011.11.025","article-title":"Anti TNF-\u03b1 in refractory Takayasu's arteritis: cases series and review of the literature","volume":"11","year":"2012","journal-title":"Autoimmun Rev"},{"key":"bib48-20250802","first-page":"291","article-title":"Takayasu arteritis: anti-TNF therapy in a Brazilian setting","volume":"50","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"bib49-20250802","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/rheumatology\/key197","article-title":"Certolizumab pegol in the treatment of Takayasu arteritis","volume":"57","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"bib50-20250802","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2017.12.066","article-title":"Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide","volume":"266","year":"2018","journal-title":"Int J Cardiol"},{"key":"bib51-20250802","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1536\/ihj.54.405","article-title":"Tocilizumab for the treatment of patients with refractory Takayasu arteritis","volume":"54","year":"2013","journal-title":"Int Heart J"},{"key":"bib52-20250802","first-page":"171","article-title":"The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis","volume":"35 Suppl 103","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"bib53-20250802","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.autrev.2013.06.019","article-title":"Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review","volume":"12","year":"2013","journal-title":"Autoimmun Rev"},{"key":"bib54-20250802","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/1756-185X.12220","article-title":"Rapid control of disease activity by tocilizumab in 10 \u2018difficult-to-treat\u2019 cases of Takayasu arteritis","volume":"16","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"bib55-20250802","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","article-title":"Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)","volume":"77","year":"2018","journal-title":"Ann Rheum Dis [Internet]"},{"key":"bib56-20250802","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/rheumatology\/keab635","article-title":"Efficacy and safety of TNF-\u03b1 antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients","volume":"61","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"bib57-20250802","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.semarthrit.2020.01.005","article-title":"Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis","volume":"50","year":"2020","journal-title":"Semin Arthritis Rheum [Internet]"},{"issue":"Suppl","key":"bib58-20250802","first-page":"S111","article-title":"Current status of Takayasu arteritis in India","volume":"54","year":"1996","journal-title":"Int J Cardiol"},{"key":"bib59-20250802","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.40037","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis","volume":"69","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"bib60-20250802","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/s41467-020-15088-0","article-title":"Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis","volume":"11","year":"2020","journal-title":"Nat Commun [Internet]"},{"key":"bib61-20250802","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/ard.2011.153007","article-title":"Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab","volume":"71","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"bib62-20250802","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8028-z","article-title":"Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?","volume":"34","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"bib63-20250802","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10067-014-2506-5","article-title":"Two Takayasu arteritis patients successfully treated with rituximab","volume":"33","year":"2014","journal-title":"Clin Rheumatol"},{"key":"bib64-20250802","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00296-019-04390-w","article-title":"Refractory Takayasu arteritis successfully treated with rituximab: case-based review","volume":"39","year":"2019","journal-title":"Rheumatol Int"},{"key":"bib65-20250802","first-page":"1","article-title":"Remission achieved in refractory advanced Takayasu arteritis using rituximab","volume":"2012","year":"2012","journal-title":"Case Rep Rheumatol [Internet]"},{"key":"bib66-20250802","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1253\/circj.CJ-09-0905","article-title":"Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis","volume":"74","year":"2010","journal-title":"Circ J"},{"key":"bib67-20250802","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.005","article-title":"Stroke and transient ischemic attack in Takayasu's arteritis: a systematic review and meta-analysis","volume":"25","year":"2016","journal-title":"J Stroke Cerebrovasc Dis [Internet]"},{"key":"bib68-20250802","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/rheumatology\/kex300","article-title":"Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis","volume":"56","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"bib69-20250802","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.semarthrit.2017.11.001","article-title":"Ischemic complications in Takayasu's arteritis: a meta-analysis","volume":"47","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"bib70-20250802","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.mayocp.2013.04.025","article-title":"Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients","volume":"88","year":"2013","journal-title":"Mayo Clin Proc [Internet]"},{"key":"bib71-20250802","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/art.20922","article-title":"Takayasu's arteritis: a study of 104 Italian patients","volume":"53","year":"2005","journal-title":"Arthritis Rheum [Internet]"},{"key":"bib72-20250802","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3899\/jrheum.150447","article-title":"Retrospective comparison of open versus endovascular procedures for Takayasu arteritis","volume":"43","year":"2016","journal-title":"J Rheumatol [Internet]"},{"key":"bib73-20250802","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/rheumatology\/kei245","article-title":"Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu's arteritis","volume":"45","year":"2006","journal-title":"Rheumatology"},{"key":"bib74-20250802","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.semarthrit.2017.03.009","article-title":"Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement","volume":"47","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"bib75-20250802","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jvs.2005.10.010","article-title":"Takayasu's arteritis: operative results and influence of disease activity","volume":"43","year":"2006","journal-title":"J Vasc Surg"},{"key":"bib76-20250802","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/BOR.0000000000000127","article-title":"Takayasu arteritis: surgical interventions","volume":"27","year":"2015","journal-title":"Curr Opin Rheumatol [Internet]"},{"key":"bib77-20250802","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2015.12.006","article-title":"Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: two-year results","volume":"205","year":"2016","journal-title":"Int J Cardiol"},{"key":"bib78-20250802","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ejrad.2013.06.019","article-title":"Long term results of endovascular treatment in renal arterial stenosis from Takayasu arteritis: angioplasty versus stent placement","volume":"82","year":"2013","journal-title":"Eur J Radiol"},{"key":"bib79-20250802","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/159101991101700219","article-title":"Outcomes after endovascular treatment of symptomatic patients with Takayasu's arteritis","volume":"17","year":"2011","journal-title":"Interv Neuroradiol"},{"key":"bib80-20250802","first-page":"102","article-title":"Takayasu's arteritis: vascular interventions and outcomes","volume":"31","year":"2004","journal-title":"J Rheumatol"},{"key":"bib81-20250802","first-page":"161","article-title":"The results of treatment in renal artery stenosis due to Takayasu disease: comparison between surgery, angioplasty, and stenting. A monocentrique retrospective study","volume":"36","year":"2015","journal-title":"G Chir"},{"key":"bib82-20250802","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1583\/11-3692.1","article-title":"Endovascular stenting vs. extrathoracic surgical bypass for symptomatic subclavian steal syndrome","volume":"19","year":"2012","journal-title":"J Endovasc Ther"},{"key":"bib83-20250802","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.111.058032","article-title":"Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience","volume":"125","year":"2012","journal-title":"Circulation [Internet]"},{"key":"bib84-20250802","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)","volume":"35","year":"2014","journal-title":"Eur Heart J [Internet]"},{"key":"bib85-20250802","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1161\/CIRCULATIONAHA.105.535724","article-title":"Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality","volume":"112","year":"2005","journal-title":"Circulation [Internet]"},{"key":"bib86-20250802","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"bib87-20250802","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"bib88-20250802","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.25061","article-title":"Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review","volume":"62","year":"2010","journal-title":"Arthritis Rheum [Internet]"},{"key":"bib89-20250802","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.fertnstert.2016.07.1102","article-title":"Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy","volume":"106","year":"2016","journal-title":"Fertil Steril [Internet]"},{"key":"bib90-20250802","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.medcli.2019.01.010","article-title":"Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases","volume":"152","year":"2019","journal-title":"Med Clin (Barc) [Internet]"},{"key":"bib91-20250802","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/kex333","article-title":"Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited","volume":"57","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1 Suppl 64","key":"bib92-20250802","first-page":"S86","article-title":"Assessment of disease activity and progression in Takayasu's arteritis","volume":"29","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"bib93-20250802","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s42358-019-0087-3","article-title":"Translation and validation of the Indian Takayasu Clinical Activity Score (ITAS2010) for the Brazilian Portuguese language","volume":"59","year":"2019","journal-title":"Adv Rheumatol [Internet]"},{"key":"bib94-20250802","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3899\/jrheum.121073","article-title":"Homocysteine levels in Takayasu arteritis-a risk factor for arterial ischemic events","volume":"40","year":"2013","journal-title":"J Rheumatol"},{"key":"bib95-20250802","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0038-1650353","article-title":"Hypercoagulable state in patients with Takayasu's arteritis","volume":"75","year":"1996","journal-title":"Thromb Haemost"},{"key":"bib96-20250802","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1253\/circj.70.600","article-title":"P-selectin expression, but not GPIIb\/IIIa activation, is enhanced in the inflammatory stage of Takayasu's arteritis","volume":"70","year":"2006","journal-title":"Circ J"},{"key":"bib97-20250802","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0049-3848(01)00349-8","article-title":"Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis","volume":"104","year":"2001","journal-title":"Thromb Res"},{"key":"bib98-20250802","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semarthrit.2012.11.001","article-title":"Aortic and coronary calcifications in Takayasu arteritis","volume":"43","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"bib99-20250802","article-title":"Comparison of adalimumab and tofacitinib in the treatment of active Takayasu arteritis\u2014full text view","journal-title":"ClinicalTrials.gov [Internet]"},{"key":"bib100-20250802","article-title":"Comparison of tofacitinib and methotrexate in Takayasu's arteritis\u2014full text view","journal-title":"ClinicalTrials.gov [Internet]"},{"key":"bib101-20250802","article-title":"A study of ustekinumab in participants with Takayasu arteritis (TAK)\u2014full text view","journal-title":"ClinicalTrials.gov [Internet]"},{"key":"bib102-20250802","article-title":"A study to evaluate the efficacy and safety of upadacitinib in participants with Takayasu arteritis (TAK)\u2014full text view","journal-title":"ClinicalTrials.gov [Internet]"},{"key":"bib103-20250802","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s10067-020-05555-w","article-title":"Current status of the rheumatologists' workforce in Latin America: a PANLAR collaborative study","volume":"40","year":"2021","journal-title":"Clin Rheumatol [Internet]"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0000000000002004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T20:04:21Z","timestamp":1754165061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0000000000002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0000000000002004","relation":{},"ISSN":["1536-7355","1076-1608"],"issn-type":[{"value":"1536-7355","type":"electronic"},{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}